Company / Cash per Share
Cue Biopharma, Inc. Cash per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.44
FY2025
5-year range
$0.44 / $2.12
FY2021-FY2025
Trend
-7.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has declined for 5 consecutive years, from $2.82 in FY2020 to $0.44 in FY2025.
Based on SEC 10-K filings.
0.44 in FY2025 with a 5-year CAGR of -31.1%.
Declined from $1.03 to $0.44 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -35.1%
- 5-Year CAGR
- -31.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- Cue Biopharma, Inc.'s cash per share has declined for 5 consecutive years.
- In FY2025, cash per share decreased 7.7% year-over-year.
- Peak cash per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -7.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.44 | -7.7% |
| FY2024 | $0.48 | -53.7% |
| FY2023 | $1.03 | -35.9% |
| FY2022 | $1.60 | -24.4% |
| FY2021 | $2.12 | -24.8% |
| FY2020 | $2.82 | +31.7% |
| FY2019 | $2.14 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026